Linkedin Facebook Twitter Youtube

22 Jul Avobis Bio

Posted at 16:42h in by

Tiffany Brown, Ph.D., CEO

Oct. 9 | 10:45am | FLW Ballroom F 

Newark, Delaware

(Private)

Avobis Bio is a clinical-stage biotechnology company dedicated to the development of implantable cell therapies to treat debilitating conditions. The investigational portfolio leverages the combination of mesenchymal stem cells and bioabsorbable materials to create novel curative treatments. In an ongoing multicenter randomized Phase II clinical trial, the investigational cell therapy AVB-114 is being assessed for persistent Crohn’s anal fistulas. Formed as a joint venture between Mayo Clinic and W. L. Gore & Associates, Avobis leverages expertise in clinical care, cell biology, materials science and commercialization of medical products to transform patient lives.

www.avobisbio.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 6-8, 2025
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions